EUVIMEDEUVIMED entdecken
Crossref

Effect of sex differences and time of oxytocin administration on treatment of rat model of autism spectrum disorder: Focused on necroptosis markers

Marjan Shariatpanahi, Zahra Sojoudi, Fariba Khodagholi, Hiva Rahmati, Seyed Behnamedin Jameie, Mina Eftekharzadeh, Maryam Soleimani Karizmeh, Mostafa Shabani, Ehsan Zamani iD

International Journal of Developmental Neuroscience · 2023

DOI: 10.1002/jdn.10286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2023. Verfasst von Marjan Shariatpanahi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Oxytocin, Autism Spectrum Disorder, Necroptosis, Sex Characteristics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Guilan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism is a neurodevelopmental disorder. A variety of molecular and cellular abnormalities leads to behavioral deficits in autism. Nevertheless, its etiology and treatment strategy are not completely understood. Oxytocin has recently shown improvements in social functioning. This study aimed to evaluate the necroptosis pathway for the neuroprotective effects of oxytocin in the valproic acid‐induced autism spectrum disorder model. The autism spectrum disorder was induced by valproic acid on gestational day 12.5 (600 mg/kg, intraperitoneally). Offspring received intranasal oxytocin (1 μg/μL) on the 21st and 40th days after birth. The offspring behaviors were scrutinized by self‐grooming, marble‐burying, three‐chamber, and Morris water maze tests. Western blot was performed on the hippocampus and amygdala tissues to investigate the expression of RIP3 and MLKL markers. The valproic acid group demonstrated more anxiety, repetitive behaviors, and expression of RIP3 and MLKL markers, and less social interaction and spatial memory compared with the control group. Oxytocin considerably improved social interactions, preference for social novelty, and memory. The elevated expression of RIP3 and MLKL markers in valproic acid‐induced autistic rats were alleviated after treatment with oxytocin. We also highlighted the importance of age and gender in autism spectrum disorder interventions. Our findings suggested that oxytocin administration was as an effective treatment in two areas of repetitive/stereotyped behaviors, social interactions/cognitive function. Notably, early administration of oxytocin resulted in better therapeutic responses in autism‐like behaviors. The molecular tests introduce oxytocin as a potential candidate for reducing the expression of necroptosis mediators in the brain. This reinforced our hypothesis that the necroptosis pathway takes part in autism spectrum disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxytocinAutism Spectrum DisorderNecroptosisSex CharacteristicsAnimalsRatsMaleFemaleValproic AcidDisease Models, AnimalPregnancyMaze LearningPrenatal Exposure Delayed EffectsTime FactorsBehavior, AnimalRats, Wistar

Stichwörter der Autor:innen

autism spectrum disordernecroptosisneurodegenerativeoxytocinratsvalproic acid

Substanzen

OxytocinValproic Acid

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
  • Neuroscience Research Center (NRC), Iran University of Medical Sciences, Tehran, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
  • Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
  • Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Ehsan Zamani

Förderung

  • Guilan University of Medical Sciences

Zitieren

APA

Shariatpanahi, M., Sojoudi, Z., Khodagholi, F., Rahmati, H., Jameie, S. B., Eftekharzadeh, M., Karizmeh, M. S., Shabani, M., & Zamani, E. (2023). Effect of sex differences and time of oxytocin administration on treatment of rat model of autism spectrum disorder: Focused on necroptosis markers. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.10286

Vancouver

Shariatpanahi M, Sojoudi Z, Khodagholi F, Rahmati H, Jameie SB, Eftekharzadeh M, et al. Effect of sex differences and time of oxytocin administration on treatment of rat model of autism spectrum disorder: Focused on necroptosis markers. International Journal of Developmental Neuroscience. 2023. doi:10.1002/jdn.10286

BibTeX
@article{Shariatpanahi2023,
  author = {Shariatpanahi, Marjan and Sojoudi, Zahra and Khodagholi, Fariba and Rahmati, Hiva and Jameie, Seyed Behnamedin and Eftekharzadeh, Mina and Karizmeh, Maryam Soleimani and Shabani, Mostafa and Zamani, Ehsan},
  title = {Effect of sex differences and time of oxytocin administration on treatment of rat model of autism spectrum disorder: Focused on necroptosis markers},
  journal = {International Journal of Developmental Neuroscience},
  year = {2023},
  doi = {10.1002/jdn.10286}
}
Kostenlos starten →